Sera Prognostics, Inc.
SERA
Rank in Stocks
#20449
Sera Prognostics, Inc. is a women's health diagnostics firm that focuses on... Sera Prognostics, Inc. is a women's health diagnostics firm that focuses on creating, advancing, and bringing to market biomarker tests aimed at improving pregnancy results. Their primary product, the PreTRM test, is a blood-based biomarker assay specifically designed to predict the likelihood of spontaneous preterm birth in singleton pregnancies where no symptoms are yet present. Additionally, the company is cultivating a portfolio of potential tests for various other pregnancy-related conditions, such as preeclampsia, predicting time-to-birth at a molecular level, gestational diabetes mellitus, restricted fetal growth, stillbirth, and postpartum depression. Established in 2008, the organization's main operations are based in Salt Lake City, Utah.
Share Price
$2.19
Last synced: 2026-11-09
Market Cap
$84.27M
Change (1 day)
0.00%
Change (1 year)
-18.59%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Sera Prognostics, Inc. (SERA)
Category
Healthcare
EPS for Sera Prognostics, Inc. (SERA)
EPS as of September 2026 TTM: $-0.67
According to Sera Prognostics, Inc.'s latest financial reports, its current EPS (TTM) is $-0.67. At the end of 2025 the company had an EPS of $-0.67, an increase over its 2024 EPS of $-0.99.
EPS history for Sera Prognostics, Inc. from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.67 | 0.00% |
| 2025 | $-0.67 | -32.32% |
| 2024 | $-0.99 | -14.66% |
| 2023 | $-1.16 | -18.88% |
| 2022 | $-1.43 | 21.19% |
| 2021 | $-1.18 | -0.84% |
| 2020 | $-1.19 | 5.31% |
| 2019 | $-1.13 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $18.99 | -2,934.33% |
US
|
|
| $6.12 | -1,013.43% |
US
|
|
| $1.38 | -305.54% |
CN
|
|
| $14.83 | -2,313.43% |
US
|
|
| $5.09 | -859.70% |
US
|
Questions about Sera Prognostics, Inc.'s earnings per share (EPS)
What is Sera Prognostics, Inc.'s earnings per share (EPS)?
Sera Prognostics, Inc.'s earnings per share (EPS) over the last twelve months is $-0.67, as of Sep 2026.
What was Sera Prognostics, Inc.'s earnings per share (EPS) in 2025?
In 2025, Sera Prognostics, Inc.'s earnings per share (EPS) was $-0.67, compared with $-0.99 in 2024.
How has Sera Prognostics, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Sera Prognostics, Inc.'s earnings per share (EPS) was highest in 2025 ($-0.67) and lowest in 2022 ($-1.43).
How does Sera Prognostics, Inc.'s earnings per share (EPS) compare with similar companies?
Sera Prognostics, Inc.'s earnings per share (EPS) ($-0.67) is lower than that of all 5 similar companies listed above. The highest among them is Thermo Fisher Scientific Inc., with $18.99.